Among different insulin signaling pathways, available treatments for diabetes usually trigger the AMPK pathway which is insulin independent93 and metformin activated that results in the inhibition of NF-kB activity in endothelial cells94, 95. Here, NFKB1 is linked to diabetes mellitus.